Print this page

Income Statement 

XLS

EUR million

Q1 – 2011

Q1 – 2010

Sales

2,477.5

2,022.8

Royalty, license and commission income

86.2

76.1

Total revenues

2,563.8

2,098.9

 

 

 

Cost of sales

–639.6

–486.6

Gross margin

1,924.1

1,612.2

 

 

 

Marketing and selling expenses

–591.6

–468.2

Royalty, license and commission expenses

–111.3

–122.2

Administration expenses

–124.9

–104.4

Other operating expenses and income

–97.1

–134.9

Research and development

–379.5

–347.2

Amortization of intangible assets

–248.2

–140.5

Investment result

Operating result

371.6

294.8

 

 

 

Exceptional items

158.0

Earnings before interest and tax (EBIT)

529.5

294.8

 

 

 

Financial result

–68.3

–38.6

Profit before tax

461.2

256.1

 

 

 

Income tax

–117.0

–61.5

Profit after tax

344.2

194.6

 

 

 

Non-controlling interest

–3.1

–3.1

Net profit after non-controlling interest

341.1

191.4

 

 

 

Earnings per share (in EUR)

 

 

basic

1.57

0.88

diluted

1.57

0.88

© Merck KGaA, Darmstadt, Germany, Last Update 2010/10/26